Search the Newsreel

Primerica, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:PRI) 2026-08-06

Primerica, Inc. (NYSE: PRI) released its Q2 2026 earnings call presentation. The company reported an EPS of $6.41, beating estimates by $0.40, and revenue of $865.07M, which missed estimates by $5.84M but represented a 9.04% year-over-year increase. The presentation was published for investors in …

Primerica, Inc. Q2 2026: Revenue $865.1M, EPS $6.45— 10-Q Summary

Primerica, Inc. reported strong second-quarter 2026 results with significant year-over-year increases in revenue, net income, and diluted EPS, driven by growth in ISP fees, higher net premiums, and stronger client asset values. The company saw continued momentum in ISP-driven products and an increase in …

Primerica, Inc. Announces Quarterly Dividend of $1.20 (NYSE:PRI)

Primerica, Inc. (NYSE:PRI) has declared a quarterly dividend of $1.20 per share, payable on September 14th to shareholders of record on August 21st. This dividend represents an annualized payout of $4.80 and a yield of 1.5%, with a strong payout ratio of 21.1%. The …

Prime Medicine, Inc. 2026: Revenue $11.04M, EPS ($0.24) — 10-Q Summary

Prime Medicine, Inc. (PRME) reported its Q2 2026 financial results, showing revenue of $11.04 million and a net loss of ($42.11M), resulting in a diluted EPS of ($0.24). This represents a decrease in revenue but an improvement in net loss and EPS compared to …

BRIEF-Prime Medicine, Inc. Q2 EPS USD -0.24

Prime Medicine, Inc. reported its Q2 earnings per share (EPS) at USD -0.24. This brief update was sourced from Reuters and made available on TradingView.

Prime Medicine expects 2027 data from two liver gene therapies

Prime Medicine reported its second-quarter 2026 financial results, including a narrowed net loss of $42.1 million and cash reserves of $108.8 million, expected to fund operations into 2027. The company announced significant pipeline progress, with initial clinical data for its two liver gene therapies, …

Prime Financial Group (ASX:PFG) Slips as Financials Sector Comes Under Pressure

Statutory Profit Doesn't Reflect How Good Primeserv Group's (JSE:PMV) Earnings Are

Primerica Q2 2026 slides: investment business drives 17% EPS growth By Investing.com

Primerica (NYSE: PRI) reported strong Q2 2026 results, with adjusted operating EPS growing 17% year-over-year to $6.41, exceeding analyst estimates. This growth was primarily fueled by its Investment & Savings Products segment, which saw revenues surge 21% and pre-tax operating income jump 31%, while …

First Trust Advisors LP Buys 14,456 Shares of PrimeEnergy Corporation $PNRG

First Trust Advisors LP significantly increased its stake in PrimeEnergy Corporation (PNRG) by 679.3%, adding 14,456 shares to own a total of 16,584 shares valued at $3.86 million. This increase follows PrimeEnergy's recent financial results where it missed consensus estimates for both EPS ($1.82 …

PrimeEnergy (PNRG) to Release Quarterly Earnings on Friday

Prime Medicine (NASDAQ:PRME) Announces Earnings Results, Meets Estimates

Prime Medicine (NASDAQ:PRME) announced its earnings results, reporting a quarterly loss of $0.24 per share, which matched analysts' consensus estimates. Despite this, the company continues to face deeply negative profitability metrics, including a net margin of -4,917.55%. Shares traded down to $2.95, near its …

ETFs Investing in Primerica, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Primerica, Inc. It provides details such as market value, weight, issuer, management style, focus, expense ratio, and assets under management (AUM) for each ETF. The information aims to help investors identify funds …

DENIZ YATIRIM - KAP Haberleri - 2026-08-06 tarihli

Primeenergy Resources Corp (PNRG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Primeenergy Resources Corp (PNRG), indicating a current earnings forecast score of 4.00, ranking 88 out of 97 in the Oil & Gas industry. Based on analysis from one analyst, the stock is rated as a "Sell" with …

Prime Medicine, Inc. (PRME) stock price, news, quote and history

This Yahoo Finance page provides comprehensive information on Prime Medicine, Inc. (PRME), including its current stock price, trading activity, historical data, and company overview. It highlights key financial metrics, recent news, performance comparisons against the S&P 500, and analyst ratings, alongside details of its …

Earnings rise and new tax equity deal at Primerica (NYSE: PRI)

Primerica (NYSE: PRI) reported increased profits and revenues for Q2 2026, with total revenues reaching $865,067 thousand and net income rising to $202,278 thousand. Diluted EPS grew to $6.45 from $5.40 in the previous year. The company also entered a $110.0 million solar tax …

Primerica (NYSE:PRI) Sets New 12-Month High Following Earnings Beat

Primerica (NYSE:PRI) reached a new 52-week high after reporting quarterly earnings per share of $6.41, surpassing estimates by $0.38, though revenue of $865.07 million missed the consensus forecast. Analyst sentiment is mixed, with a "Hold" consensus and an average price target of $308.67, despite …

Prime Medicine, Inc. (PRME) Reports Q2 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) reported a Q2 loss of $0.24 per share, aligning with Zacks Consensus Estimate but missing revenue estimates significantly at $1.15 million. The company has consistently missed revenue expectations over the last four quarters, and its shares have underperformed the S&P …

FDA milestones and Beam ruling frame outlook for Prime Medicine (NASDAQ: PRME)

Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Prime Medicine has reported its second-quarter 2026 financial results, highlighting significant progress in its clinical programs. The company received IND and CTA clearances for PM577a in Wilson disease, securing a global Phase 1/2 program, and an arbitration resolution affirmed its rights to PM647 for …

Prime Focus Q1FY27 revenue rises 24% to ₹1,267cr; EBITDA at ₹301cr

Prime Medicine (PRME) Earnings Date and Reports 2026

Primerica (NYSE:PRI) Releases Earnings Results, Beats Estimates By $0.38 EPS

Primerica (NYSE:PRI) reported strong quarterly earnings, beating analyst estimates by $0.38 with an EPS of $6.41. The company's revenue increased 9% year-over-year, and its shares rose 0.6% following the announcement. Despite mixed analyst sentiment, Primerica's stock is trading near its 52-week high, with a …

Q1 Results: LIC, Trent, Britannia, HeroMoto Corp, Lupin, Premier Energies, Prime Focus, others to post earnings on Aug 6

Primerica (PRI) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Primerica (PRI) reported revenue of $863.38 million, up 8.5% over the same period last year. EPS came in at $6.41, compared to $5.46 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $872.5 …

Primerica (NYSE:PRI) Posts Q2 CY2026 Sales In Line With Estimates

Primerica (NYSE:PRI) reported Q2 CY2026 results, with sales of $865.1 million, aligning with Wall Street estimates, and a non-GAAP profit of $6.41 per share, beating analyst consensus. Despite net premiums earned missing estimates and book value per share falling slightly short, the company demonstrated …

Perimeter Solutions (PRM) Stock Could Be 11% Undervalued After Contract Friction

Perimeter Solutions (PRM) stock's valuation presents a mixed picture; while a Discounted Cash Flow (DCF) analysis suggests it could be 11.2% undervalued at $39.38 per share, market multiples and an overall low valuation score indicate it's more expensive. The stock has seen significant returns …

Primerica Q2 FY26 EPS rises 19% to $6.45; revenue increases 9% to $865 million

Primerica reported strong second-quarter fiscal year 2026 results, with EPS increasing 19% to $6.45 and total revenue rising 9% to $865 million. This growth was driven by higher commissions and fees from improved investment results. The company also saw a significant increase in Investment …

Primerica Reports Second Quarter 2026 Results

Record investment sales of $4.4 billion, up 23% All-time high client asset values ended the quarter at $140 billion, up 16% Life-licensed sales force totaled 148,612 at June 30, 2026 Net premiums increased 1%; adjusted direct premiums increased 3% Net earnings per diluted share …

Primerica Client Assets Reach All-Time High of $140 Billion

Primerica (NYSE: PRI) reported strong financial results for Q2 2026, with net earnings per diluted share increasing 19% to $6.45 and adjusted operating EPS rising 17% to $6.41. The company achieved record investment sales of $4.4 billion, up 23%, and client asset values reached …

Earnings Flash (PRI) Primerica, Inc. Reports Q2 Revenue $865.1M, vs. FactSet Est of $881.0M

Primerica, Inc. (PRI) reported Q2 revenue of $865.1 million, falling short of FactSet's estimate of $881.0 million. This financial update was published on August 5, 2026, at 04:58 pm EDT. The company also announced its Q2 adjusted EPS of $6.41 per share, exceeding FactSet's …

Primerica in the spotlight: Can annuity boom lift earnings?

Primerica Inc. is set to announce its second-quarter earnings, with analysts anticipating modest EPS growth despite a slight revenue dip. The key focus for investors will be the performance of the Investment & Savings Products segment, especially its ability to capitalize on the surging …

Perimeter Solutions, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:PRM) 2026-08-04

Perimeter Solutions, Inc. (NYSE:PRM) published its slide deck for the 2026 Q2 earnings call. The company reported an EPS of $0.35, missing estimates by $0.05, and revenue of $213.81M, missing by $8.19M, despite a 31.46% year-over-year increase. This presentation provides details related to their …

Perimeter Solutions (PRM) gains 8.2% institutional holder as Principal units disclose stake

Principal Global Investors, LLC and Principal Funds, Inc. have reported an 8.2% beneficial ownership stake in Perimeter Solutions, Inc. (PRM) as of June 30, 2026. This includes 13,375,024 shares with shared voting and dispositive power for Principal Global Investors, and 9,151,796 shares (5.6%) for …

Perimeter Solutions Inc (PRM) Stock Up 5.2% but GF Value Says Ov

Perimeter Solutions Inc (PRM) saw its stock rise by 5.2% to $34.97, but GuruFocus' GF Value indicates the stock is 83.8% overvalued compared to its estimated intrinsic value of $19.03. The company has an average GF Score of 49/100, with strong momentum but weak …